Filtering Out Use of DOACs in Hemodialysis. - Wikidata - awgldk - TriplyDB

Filtering Out Use of DOACs in Hemodialysis.

Filtering Out Use of DOACs in Hemodialysis.

http://www.wikidata.org/entity/Q39003917

about

A Multicenter Retrospective Analysis of Factors Associated With Apixaban-Related Bleeding in Hospitalized Patients With End-Stage Renal Disease on Hemodialysis.

P2860

Q38712570-4A3ABFC5-93A7-4EAB-8F89-F042C341616A

P2860

Filtering Out Use of DOACs in Hemodialysis.

http://www.wikidata.org/entity/Q39003917

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Filtering Out Use of DOACs in Hemodialysis.

@en

Filtering Out Use of DOACs in Hemodialysis.

@nl

type

label

Filtering Out Use of DOACs in Hemodialysis.

@en

Filtering Out Use of DOACs in Hemodialysis.

@nl

prefLabel

Filtering Out Use of DOACs in Hemodialysis.

@en

Filtering Out Use of DOACs in Hemodialysis.

@nl

P1433

Q39003917-BA800400-2CE6-4EA5-9A1F-C2BD7FF3E6E5

P1476

Q39003917-F1767E69-F35C-4878-9F80-F3106582D5ED

P2093

Q39003917-6B20884A-C844-41A0-A403-17EFCAE374C4

Q39003917-F67AB4FA-18BF-4DFA-B7B6-C4AF9C8E21B6

P2860

Q39003917-0C8F8C7C-9FD0-4C71-9682-25145DE84CA4

Q39003917-46536023-C606-47F8-912E-6459202A2AC5

Q39003917-72E42DF0-FA0E-40F8-A10C-E960B9504AEE

Q39003917-746A891F-1FA1-4ED2-97B0-5ED00BA4AE0B

Q39003917-8A6BB5B9-9E30-4FFD-A947-2292AB900A28

Q39003917-8B6327D2-437D-4CA9-83F4-9F3F6487BA6A

Q39003917-A7C2EE39-A394-4CA9-9780-E021AAC69DDE

Q39003917-A852B997-8D99-4434-A86B-570A81C58836

Q39003917-C7F676B9-2B7D-4267-A56B-59186EA280C2

Q39003917-D5636498-1D99-4B1D-B0A2-03C8BF867B06

P304

Q39003917-755CEDBC-DCED-44FF-8BBF-27341DDD33E1

P31

Q39003917-8086E698-2C8A-4E9C-BE4A-423E7DE77B49

P356

Q39003917-6ECA9AC4-BC53-4B23-8352-38707A313FC0

P407

Q39003917-BDDC30A3-95C8-46F1-BC1B-998C6B54E060

P433

Q39003917-A752C4A6-B5FD-489D-94D1-0413FED6836B

P478

Q39003917-A7BD525D-D44F-4A31-A675-82BADE40A539

P577

Q39003917-2D5659FD-94DA-43CE-91FD-ECADCDB613EA

P698

Q39003917-F9B0A3B2-D4B5-41A2-9F4D-7DD66EC3D3DB

P356

1060028016689265

P1433

Annals of Pharmacotherapy

P1476

Filtering Out Use of DOACs in Hemodialysis.

@en

P2093

Jin A Lee

http://www.w3.org/2001/XMLSchema#string

William E Dager

http://www.w3.org/2001/XMLSchema#string

P2860

Dabigatran and rivaroxaban use in atrial fibrillation patients on hemodialysis.

Haemostasis in chronic kidney disease.

Clinical Pharmacist Management of Bacteremia in a Community Hospital Emergency Department.

Altered platelet and vascular prostaglandin-generation in patients with renal failure and prolonged bleeding times.

Peritoneal dialysis in renal replacement therapy for patients with acute kidney injury.

Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency.

Can enoxaparin be used safely in end-stage renal disease?

Blood coagulation, fibrinolytic, and inhibitory proteins in end-stage renal disease: effect of hemodialysis.

Clinical Application and Pharmacodynamic Monitoring of Apixaban in a Patient with End-Stage Renal Disease Requiring Chronic Hemodialysis.

Effect of renal impairment on the pharmacokinetics, pharmacodynamics, and safety of apixaban.

P304

511-513

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1060028016689265

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28114796

http://www.w3.org/2001/XMLSchema#string